Reuters logo
BRIEF-Biotec Pharmacon issued new patent for cancer adjuvant therapy
August 6, 2014 / 1:15 PM / in 3 years

BRIEF-Biotec Pharmacon issued new patent for cancer adjuvant therapy

Aug 6 (Reuters) - Biotec Pharmacon ASA : * Issued new patent for cancer adjuvant therapy * Says the patent US 8,791,252 is for a method of treating a variety of different cancers by administrating a combination of a (1,3) beta-glucan and a complement-activating antibody * Source text for Eikon * Further company coverage

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below